J22352
J22352 is a PROTAC (proteolysis-targeting chimeras) -like and highly selective HDAC6 inhibitor with an IC50 value of 4.7 nM. J22352 promotes HDAC6 degradation and induces anticancer effects by inhibiting autophagy and eliciting the antitumor immune response in glioblastoma cancers, and leading to the restoration of host antitumor activity by reducing the immunosuppressive activity of PD-L1[1].
Product Specifications
CAS Number
[2252395-44-9]
UNSPSC
12352005
Target
HDAC
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/j22352.html
Concentration
10mM
Purity
99.04
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(C1=CC=CC=C1N2CC3=CC=C(C(NO)=O)C=C3)N(CCC4=CC=CC=C4)C2=O
Molecular Formula
C24H21N3O4
Molecular Weight
415.44
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HDAC6
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
LAG-3 (Lymphocyte Activation Gene 3 Protein, LAG3, CD223, FDC, Protein FDC) (Azide free) (HRP)
LAG-3 (Lymphocyte Activation Gene 3 Protein, LAG3, CD223, FDC, Protein FDC) (Azide free) (HRP)
Magic™ Membrane Protein Human P2RX1 (Purinergic receptor P2X 1) Full Length